Chronic pancreatitis: Potential future interventions

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 1022-1028

  Ansari, Daniel ^a   Andersson, Ellen ^a   Andersson, Bodil ^a   Andersson, Roland ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chronic pancreatitis; Fibrosis; Pathophysiology; Stellate cells; Treatment

Indexed keywords

ALLOPURINOL; ALPHA SMOOTH MUSCLE ACTIN; ALPHA TOCOPHEROL; ANTIOXIDANT; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DA 9601; EPIGALLOCATECHIN GALLATE; FIBRONECTIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LAMININ; LISINOPRIL; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; RETINOL; RHO KINASE; SCLEROPROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CHRONIC PANCREATITIS; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; MALIGNANT TERATOMA; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STELLATE CELL;

FIBROSIS; HUMANS; PANCREATITIS, CHRONIC;

EID: 77955547735     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521003734174     Document Type: Review

References (57)

1. Mitchell RMS, Byrne MF, Baillie J. Pancreatitis. Lancet 2003;361:1447-1455
2. Layer P, Tamamanto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early-and late-onset idio pathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481-1487
3. Bordalo O, Goncalves D, Noronha M, Cristina ML, Salgadinho A, Dreiling DA, et al. Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol 1977;68:278-285
4. Gullo L, Casadei R, Migliori M, Manca M, Bastagli L, Pezilli R, et al. A search for acute necrotic pancreatitis in early stages of alcoholic chronic pancreatitis. J Clin Gastroenterol 2006;40:435-439
5. Sarles H, Sarles J-C, Camatte R, Muratore R, Gaini M, Guien C, et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965;6:545-558
6. Payan H, Sarles H, Demirdjian M, Gauthier AP, Cros RC, Durbec JP. Study of the histological features of chronic pancreatitis by correspondence analysis. Identification of chronic calcifying pancreatitis as an entity. Rev Eur Etudes Clin Biol 1973;17:663-670
7. Uys CJ, Bank S, Marks IN. The pathology of chronic pancreatitis in Cape Town. Digestion 1973;9:454-468
8. Gullo L, Costa PL, Labo G. Chronic pancreatitis in Italy: aetiological, clinical and histological observations based on 253 cases. Rendic Gastroenterol 1977;9:97-104.
9. Sahel J, Cros RC, Durbec JP, Sarles H, Bank S, Marks IN, et al. Multicenter pathological study of chronic pancreatitis: morphological regional variations and differences between chronic calcifying pancreatitis and obstructive pancreatitis. Pancreas 1986;1:471-477
10. Migliori M, Manca M, Santini D, Pezilli R, Gullo L. Does acute alcoholic pancreatitis precede the chronic form or is the opposite true? J Clin Gastroenterol 2004;38:272-275
11. Braganza JM. Pancreatic disease: a casualty of hepatic detoxification? Lancet 1983;2:1000-1003
12. Sarles H, Bernard JP, Gullo L. Pathogenesis of chronic pancreatitis. Gut 1990;31:629-632
13. Klöppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993;8:659-670
14. Comfort MW, Gambill EE, Baggenstoss AH. Chronic relapsing pancreatitis. Gastroenterology 1946;6:239-285
15. Ammann RW, Heitz PU, Klöppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological longterm study. Gastroenterology 1996;111:224-231
16. Whitcomb DC. Gene mutations as a cause of chronic pancreatitis. In: Adler G, Amman R, Buchler M, DiMagio EP, Sarner M, Eds. Pancreatitis: Advances in pathobiology, diagnosis and treatment (Falk Symposium 143). Freiburg, Germany, October 14-15, 2004. Lancaster, UK, Springer, 2005, pp 139-152
17. Cavallini G. Is chronic pancreatitis a primary disease of the pancreatic ducts? A new pathogenetic hypothesis. Ital J Gastroenterol 1993;25:400-407
18. Kulling D, Tresch S, Renner E. Triad of sclerosing cholangitis, chronic pancreatitis, and sjogrens syndrome: Case report and review. Gastrointest Endosc 2003;57:118-120
19. Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and sjogrens syndrome: a syndrome complex. Am J Surg 1984;147:822-826
20. Ludvigsson JF, Montgomery SM, Ekbom A. Risk of pancreatitis in 14,000 individuals with celiac disease. Clin Gastroenterol Hepatol 2007;5:1347-1353
21. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-738
22. Puig-Divi V, Molero X, Salas A, Guarner F, Guarner L, Malagelada JR. Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion intro rat pancreatic ducts. Pancreas 1996;13:417-424
23. Hunger RE, Mueller C, ZGraggen K, Freiss H, Buchler MW. Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis. Gastroenterology 1997;112:1656-1663
24. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-432
25. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43:128-133
26. Tahara J, Shimizu K, Shiratori K. Engulfment of necrotic acinar cells by pancreatic stellate cells inhibits pancreatic fibrogenesis. Pancreas 2008;37:69-74.
27. Shimizu K, Kobayashi M, Tahara J, Shiratori K. Cytokines and peroxisome proliferator-activated receptor gamma ligand regulate phagocytosis by pancreatic stellate cells. Gastroenterology 2005;128:2105-2118
28. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:911-912
29. Tasci I, Deveci S, Isik AT, Comert B, Akay C, Mas N, et al. Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation. Pancreas 2007;35:366-371
30. Masamune A, Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 2009;44:249-260
31. McCarroll JA, Phillips PA, Santucci N, Pirola RC, Wilson JS, Apte MV. Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis. Gut 2006;55:79-89.
32. Gomez JA, Molero X, Vaquero E, Alonso A, Salas A, Malagelada JR. Vitamin E attenuates biochemical and morphological features associated with development of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G162-9.
33. RickmannM, Vaquero EC, Malagelada JR, Molero X. Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology 2007;132:2518-2532
34. Yoo BM, Oh TY, Kim YB, Yeo M, Lee JS, Surth YJ, et al. Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 2005;5:165-176
35. Masamue A, Kikuta K, Satoh M, Suzuki N, Shimosegawa T. Green tea polyphenol epigallocatechin-3-gallate blocks PDGF-induced proliferation and migration of rat pancreatic stellate cells. World J Gastroenterol 2005;11:3368-3374
36. Masamune A, Watanabe T, Kikuta, Satoh K, Shimosegawa T. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G99-108.
37. Mohseni Salehi Monfared SS, Vahidi H, Abdolghaffari AH, Nikfar S, Abdollahi M. Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review. World J Gastroenterol 2009;15:4481-4490
38. Zion O, Genin O, Kawada N, Yoshizato K, Roffe S, Nagler A, et al. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. Pancreas 2009;38:427-435
39. Jaster R, Sparmann G, Emmrich J, Liebe S. Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 2002;51:579-584
40. Masamune A, Satoh A, Kikuta K, Sakai Y, Satoh A, Shimosegawa T. Inhibition of p38 mitogen-activated protein kinase blocks activation of rat pancreatic stellate cells. J Pharmacol Exp Ther 2003;304:8-14.
41. Baumert JT, Sparmann G, Emmrich J, Liebe S, Jaster R. Inhibitory effect of interferons on pancreatic stellate cell activation. World J Gastroenterol 2006;12:896-901.
42. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977;57:313-370
43. Paul M, Poyan Mehr A, Kreutz R. Physiology of local reninangiotensin systems. Physiol Rev 2006;86:747-803.
44. Tsang SW, Ip SP, Leung PS. Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004;36:330-339
45. Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307:17-23.
46. Nagashio Y, Asaumi H, Watanabe S, Nomiyama Y, Taguchi M, Tashiro M, et al. Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 2004;287:G170-7.
47. Ulmasov B, Xu Z, Tetri LH, Inagami T, Neuschwander-Tetri BA. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2009;296:G284-94.
48. Tsang SW, Ip SP, Wong TP, Che CT, Leung PS. Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 2003;111:47-53.
49. Kuno A, Yamada T, Masuda K, Ogawa K, Sogawa M, Nakamura S, et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male wistar bonn/kobori rats. Gastroenterology 2003;124:1010-1019
50. van Westerloo DJ, Florquin S, de Boer AM, Daalhuisen J, de Vos AF, Bruno MJ, et al. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005;166:721-728
51. Jaster R, Brock P, Sparmann G, Emmrich J, Liebe S. Inhibition of pancreatic stellate cell activation by the hydroxymethylglutaryl coenzyme A reductase inhibitor lovastatin. Biochem Pharmacol 2003;65:1295-1303
52. Casey PJ, Solski PA, Der CJ, Buss JE. P21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 1989;86: 8323-8337
53. Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, et al. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cell activity. Lab Invest 2005;85:75-89.
54. Su SB, Motoo Y, Xie MJ, Sakai J, Taga H, Sawabu N. Expression of pancreatitis associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of the herbal medicine Saiko-keishi-to (Tj-10). Pancreas 1999;19:239-247
55. Su SB, Motoo Y, Xie MJ, Taga H, Sawabu N. Antifibrotic effect of herbal medicine Saiko-keishi-to (TJ 10) on chronic pancreatitis in WBN/Kob rat. Pancreas 2001;22:8-17.
56. Masamune A, Suzuki N, Kikuta K, Satoh M, Satoh K, Shimosewaga T. Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 2006;95:1080-1093
57. Suzuki N, Masamune A, Kikuta K, Watanabe T, Satoh K, Shimosegawa T. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Konori rats. Dig Dis Sci 2009;54:802-810